CMMB Q2 2019 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q2 2019 Earnings

Revenue

Gross Profit

Operating Income

-$4M

Net Income

-$2M

EPS (Diluted)

$-9.56

QoQ Revenue Growth

NaN%

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$17,325	+100.0%
Operating Income	-$4M	-$4M	-7.5%
Net Income	-$2M	-$5M	+65.7%